NEW YORK (TheStreet) -- Shares of Cerner Corp. (CERN - Get Report) are sinking 7.7% to $51.19 late Wednesday morning after the company reported its 2015 fourth quarter results after yesterday's market close.
The Kansas City, MO-based healthcare information technology supplier posted adjusted earnings of 61 cents per share, which beat analysts' expectations for earnings of 57 cents per share.
Revenue climbed 27% to $1.175 billion and was slightly higher than Wall Street's estimates of $1.17 billion.
Cerner adjusted its revenue outlook for 2016 after bookings in the quarter were below estimates, the Wall Street Journal noted.
For the full year, the company forecasts revenue between $4.9 billion to $5.1 billion, compared to its earlier outlook for more than $5 million in revenue.
Bookings for the fourth quarter rose by 16% to $1.35 billion, but were lower than management's guidance for new business bookings of $1.45 billion to $1.55 billion.
Cerner offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations, including software, hardware, professional services and managed services.
Separately, TheStreet Ratings Team has a "Buy" rating with a score of B on the stock.
This is driven by several positive factors, which should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks covered.
The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, growth in earnings per share and increase in net income.
The team believes its strengths outweigh the fact that the company has had lackluster performance in the stock itself.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: CERNCERN data by YCharts